BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22761154)

  • 1. Combining different design strategies for rational affinity maturation of the MICA-NKG2D interface.
    Henager SH; Hale MA; Maurice NJ; Dunnington EC; Swanson CJ; Peterson MJ; Ban JJ; Culpepper DJ; Davies LD; Sanders LK; McFarland BJ
    Protein Sci; 2012 Sep; 21(9):1396-402. PubMed ID: 22761154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations designed to destabilize the receptor-bound conformation increase MICA-NKG2D association rate and affinity.
    Lengyel CS; Willis LJ; Mann P; Baker D; Kortemme T; Strong RK; McFarland BJ
    J Biol Chem; 2007 Oct; 282(42):30658-66. PubMed ID: 17690100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic core evolution of major histocompatibility complex class I chain-related protein A for dramatic enhancing binding affinity.
    Cai W; Peng S; Tian Y; Bao Y; Liu Q; Dong Y; Liang Z; Liu Q; Ren Y; Ding P; Liu J; Xu T; Li Y
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132588. PubMed ID: 38788878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic mutation and thermodynamic analysis of central tyrosine pairs in polyspecific NKG2D receptor interactions.
    Culpepper DJ; Maddox MK; Caldwell AB; McFarland BJ
    Mol Immunol; 2011 Jan; 48(4):516-23. PubMed ID: 21074271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient In Vitro Refolding and Characterization of Major Histocompatibility Complex Class I-Related Chain Molecules A (MICA) and Natural Killer Group 2 Member D (NKG2D) Expressed in E. coli.
    Zhao X; Acheampong DO; Wang Y; Tang M; Xie W; Chen Z; Wang M; Zhang J
    Protein Pept Lett; 2015; 22(5):460-9. PubMed ID: 25925769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative Splice Transcripts for MHC Class I-like MICA Encode Novel NKG2D Ligands with Agonist or Antagonist Functions.
    Gavlovsky PJ; Tonnerre P; Gérard N; Nedellec S; Daman AW; McFarland BJ; Charreau B
    J Immunol; 2016 Aug; 197(3):736-46. PubMed ID: 27342847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.
    Steinle A; Li P; Morris DL; Groh V; Lanier LL; Strong RK; Spies T
    Immunogenetics; 2001; 53(4):279-87. PubMed ID: 11491531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA.
    Li P; Morris DL; Willcox BE; Steinle A; Spies T; Strong RK
    Nat Immunol; 2001 May; 2(5):443-51. PubMed ID: 11323699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
    Kim Y; Born C; Bléry M; Steinle A
    Front Immunol; 2020; 11():960. PubMed ID: 32582150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.
    Ashiru O; López-Cobo S; Fernández-Messina L; Pontes-Quero S; Pandolfi R; Reyburn HT; Valés-Gómez M
    Biochem J; 2013 Sep; 454(2):295-302. PubMed ID: 23772752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of human MHC class I-related chain molecule B-α1 domain.
    Wang S; Xiang Z; Wang Y; Xu H; Zhang D; Wang X; Sheng J
    Protein Expr Purif; 2016 Jul; 123():83-9. PubMed ID: 27036081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MICA-129 Dimorphism and Soluble MICA Are Associated With the Progression of Multiple Myeloma.
    Zingoni A; Vulpis E; Cecere F; Amendola MG; Fuerst D; Saribekyan T; Achour A; Sandalova T; Nardone I; Peri A; Soriani A; Fionda C; Mariggiò E; Petrucci MT; Ricciardi MR; Mytilineos J; Cippitelli M; Cerboni C; Santoni A
    Front Immunol; 2018; 9():926. PubMed ID: 29765374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular competition for NKG2D: H60 and RAE1 compete unequally for NKG2D with dominance of H60.
    O'Callaghan CA; Cerwenka A; Willcox BE; Lanier LL; Bjorkman PJ
    Immunity; 2001 Aug; 15(2):201-11. PubMed ID: 11520456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.
    Møller SH; Mellergaard M; Madsen M; Bermejo AV; Jepsen SD; Hansen MH; Høgh RI; Aldana BI; Desler C; Rasmussen LJ; Sustarsic EG; Gerhart-Hines Z; Daskalaki E; Wheelock CE; Hiron TK; Lin D; O'Callaghan CA; Wandall HH; Andresen L; Skov S
    Front Immunol; 2020; 11():1968. PubMed ID: 32849657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICA.
    Isernhagen A; Schilling D; Monecke S; Shah P; Elsner L; Walter L; Multhoff G; Dressel R
    Immunogenetics; 2016 Feb; 68(2):109-23. PubMed ID: 26585323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
    Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
    J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
    Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
    Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the HCMV UL16-MICB complex elucidates select binding of a viral immunoevasin to diverse NKG2D ligands.
    Müller S; Zocher G; Steinle A; Stehle T
    PLoS Pathog; 2010 Jan; 6(1):e1000723. PubMed ID: 20090832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
    Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
    J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.